Scholarlink

<p>As central cells involved in osteoimmunology, bone niche macrophages possess diverse functions, and their differentiation fate regulates bone homeostasis. Elucidation of the underlying mechanism involved in macrophage differentiation is important for developing new therapeutic targets for osteoporosis. Here, we show that knocking out Raf kinase inhibitor protein (RKIP), either globally or in macrophages, results in dramatically increased bone mass in mice due to synergistic inhibition of bone resorption and promotion of bone formation. Mechanistically, RKIP knockout inhibits differentiation of macrophages into osteoclasts and promotes their differentiation towards pro-angiogenic subclusters, which enhances formation of H-type vessels. RKIP enhances osteoclastogenesis by interacting with ARHGAP to suppress CDC42 inactivation. Intranuclear RKIP suppresses angiogenic genes expression by bridging the association between HIF-1α and VHL to reduce the protein stability of HIF-1α in macrophages. Furthermore, RKIP deletion or inhibitor rescues ovariectomy (OVX)-induced bone loss in vivo. Collectively, this study provides insights into the different roles of extranuclear or intranuclear RKIP in regulating differentiation of bone niche macrophages and could inform potential therapies for bone homeostasis-related diseases.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

RKIP regulates bone marrow macrophage differentiation to mediate osteoclastogenesis and H-type vessel formation

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年8月15日

查看全文
  • Zeyu Zheng,
  • Siyue Tao,
  • Jiayan Jin,
  • Yansong Li,
  • Liya Dai,
  • Zhaobo Huang,
  • Yihao Zhao,
  • Bao Huang,
  • Saijilafu,
  • Wenlong Lin,
  • Xiaojian Wang,
  • Mengrui Wu,
  • Jian Chen,
  • Fengdong Zhao

摘要

As central cells involved in osteoimmunology, bone niche macrophages possess diverse functions, and their differentiation fate regulates bone homeostasis. Elucidation of the underlying mechanism involved in macrophage differentiation is important for developing new therapeutic targets for osteoporosis. Here, we show that knocking out Raf kinase inhibitor protein (RKIP), either globally or in macrophages, results in dramatically increased bone mass in mice due to synergistic inhibition of bone resorption and promotion of bone formation. Mechanistically, RKIP knockout inhibits differentiation of macrophages into osteoclasts and promotes their differentiation towards pro-angiogenic subclusters, which enhances formation of H-type vessels. RKIP enhances osteoclastogenesis by interacting with ARHGAP to suppress CDC42 inactivation. Intranuclear RKIP suppresses angiogenic genes expression by bridging the association between HIF-1α and VHL to reduce the protein stability of HIF-1α in macrophages. Furthermore, RKIP deletion or inhibitor rescues ovariectomy (OVX)-induced bone loss in vivo. Collectively, this study provides insights into the different roles of extranuclear or intranuclear RKIP in regulating differentiation of bone niche macrophages and could inform potential therapies for bone homeostasis-related diseases.